
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Canopy Growth Corp (CGC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: CGC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $3.8
1 Year Target Price $3.8
0 | Strong Buy |
2 | Buy |
4 | Hold |
1 | Sell |
3 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -42.6% | Avg. Invested days 15 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 498.12M USD | Price to earnings Ratio - | 1Y Target Price 3.8 |
Price to earnings Ratio - | 1Y Target Price 3.8 | ||
Volume (30-day avg) 10 | Beta 2.08 | 52 Weeks Range 0.77 - 5.80 | Updated Date 08/28/2025 |
52 Weeks Range 0.77 - 5.80 | Updated Date 08/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-07 | When Before Market | Estimate -0.151 | Actual -0.1932 |
Profitability
Profit Margin -186.42% | Operating Margin (TTM) -30.61% |
Management Effectiveness
Return on Assets (TTM) -2.83% | Return on Equity (TTM) -101.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 493722312 | Price to Sales(TTM) 1.81 |
Enterprise Value 493722312 | Price to Sales(TTM) 1.81 | ||
Enterprise Value to Revenue 2.48 | Enterprise Value to EBITDA -1.06 | Shares Outstanding 239848992 | Shares Floating 239736496 |
Shares Outstanding 239848992 | Shares Floating 239736496 | ||
Percent Insiders 0.07 | Percent Institutions 7.25 |
Upturn AI SWOT
Canopy Growth Corp

Company Overview
History and Background
Canopy Growth Corp., formerly Tweed Marijuana Inc., was founded in 2013 in Smiths Falls, Ontario. It was the first cannabis producer in North America to be listed on a major stock exchange. Significant milestones include strategic investments from Constellation Brands and rapid expansion through acquisitions.
Core Business Areas
- Cannabis Cultivation and Sales: Cultivation, processing, and sale of dried cannabis, oils, capsules, and edibles for recreational and medical markets.
- Beverages: Development and sale of cannabis-infused beverages through partnerships like with Constellation Brands.
- International Expansion: Establishing a presence in international markets to cultivate, process, and distribute cannabis products.
Leadership and Structure
The leadership team includes CEO David Klein. The organizational structure involves various divisions focused on cultivation, product development, sales, and international operations. The company has a board of directors overseeing strategic direction.
Top Products and Market Share
Key Offerings
- Dried Flower: A range of dried cannabis flower products. Market share is difficult to specify due to regional variations and evolving market dynamics, but it is a significant segment. Competitors include Aurora Cannabis, Tilray, and Curaleaf.
- Market Share (%):
- Cannabis Oils and Capsules: Cannabis oil and capsule products for medical and recreational use. Competitors include Aurora Cannabis, Tilray, and Organigram.
- Market Share (%):
- Cannabis-Infused Beverages: Cannabis-infused beverages, often in partnership with Constellation Brands. Competitors include Truss Beverages (Molson Coors partnership) and other smaller infused beverage companies.
- Market Share (%):
Market Dynamics
Industry Overview
The cannabis industry is characterized by evolving regulations, increasing competition, and growing consumer acceptance. It faces challenges such as inconsistent regulations across jurisdictions and the presence of a black market.
Positioning
Canopy Growth Corp. aims to be a leading global cannabis company with a strong brand portfolio and international presence. Its competitive advantages include its early-mover status, strategic partnerships, and established cultivation infrastructure.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars in the coming years. Canopy Growth Corp. is positioned to capture a significant share of this TAM, but its success depends on navigating regulatory hurdles and effectively executing its growth strategy.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Established cultivation infrastructure
- Strategic partnership with Constellation Brands
- Early mover advantage
- International presence
Weaknesses
- Consistent losses and negative cash flow
- Overexpansion and high operating costs
- Complex regulatory environment
- Inconsistent product quality
Opportunities
- Expanding into new international markets
- Developing innovative cannabis products
- Capitalizing on increasing legalization trends
- Optimizing production processes
- Partnerships with other companies
Threats
- Intense competition
- Changing regulations
- Black market
- Economic downturn
- Price volatility
Competitors and Market Share
Key Competitors
- TLRY
- ACB
- CRON
- CURLF
Competitive Landscape
Canopy Growth Corp. faces intense competition from other cannabis companies. Its advantages include its strong brand and partnerships, but its disadvantages include its high costs and losses.
Major Acquisitions
Supreme Cannabis
- Year: 2021
- Acquisition Price (USD millions): 346
- Strategic Rationale: Acquisition to strengthen product portfolio and market share in the Canadian recreational cannabis market.
Growth Trajectory and Initiatives
Historical Growth: Canopy Growth Corp. experienced rapid revenue growth in its early years but has since faced challenges in achieving profitability.
Future Projections: Analyst projections vary widely depending on the company's ability to improve its financial performance and capitalize on market opportunities. Analyst data should be looked up on financial websites.
Recent Initiatives: Recent initiatives include cost-cutting measures, restructuring operations, and focusing on core markets.
Summary
Canopy Growth Corp. is a cannabis company that has faced challenges in achieving profitability despite its early-mover advantage and brand recognition. While strategic partnerships provide potential, consistent losses and intense competition remain concerns. Focus on cost reduction and market penetration will be critical for future success. The fluctuating cannabis regulations and overall cannabis market volatility add another layer of risk.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Market Research Reports
- Financial News Articles
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market data is subject to change. Historical market share data is difficult to confirm precisely.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Canopy Growth Corp
Exchange NASDAQ | Headquaters Smiths Falls, ON, Canada | ||
IPO Launch date 2014-04-04 | CEO & Director Mr. Luc Mongeau | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 960 | Website https://www.canopygrowth.com |
Full time employees 960 | Website https://www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.